Patents by Inventor Thang D. Dinh

Thang D. Dinh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cyclohexyl prostaglandin analogs as EP-receptor agonists
    Patent number: 7473704
    Abstract: The invention relates to the use of novel cyclohexyl analogues of E-type prostaglandins as EP4 agonists, in general, and, in particular as ocular hypotensives. The cyclohexyl analogues used in accordance with the invention are represented by the following formula I: wherein the wavy segments represent ? or ? bond, dashed line represents the presence or absence of a bond W, Y, Z, R, R1, R2 and R3 are as defined in the specification.
    Type: Grant
    Filed: September 30, 2005
    Date of Patent: January 6, 2009
    Assignee: Allergan, Inc.
    Inventors: David W. Old, Robert M. Burk, Thang D. Dinh
  • Cyclohexyl prostaglandin analogs as EP-receptor agonists
    Patent number: 7429615
    Abstract: The invention relates to the use of novel cyclohexyl analogues of E-type prostaglandins as EP4 agonists, in general, and, in particular as ocular hypotensives. The cyclohexyl analogues used in accordance with the invention are represented by the following formula I: wherein the wavy segments represent ? or ? bond, dashed line represents the presence or absence of a bond W, Y, Z, R, R1, R2 and R3 are as defined in the specification.
    Type: Grant
    Filed: August 16, 2004
    Date of Patent: September 30, 2008
    Assignee: Allergan, Inc.
    Inventors: David W. Old, Robert M. Burk, Thang D. Dinh
  • Cyclohexyl prostaglandin analogs as EP-receptor agonists
    Patent number: 7015243
    Abstract: The invention relates to the use of novel cyclohexyl analogues of E-type prostaglandins as EP4 agonists, in general, and, in particular as ocular hypotensives. The cyclohexyl analogues used in accordance with the invention are represented by the following formula I: wherein the wavy segments represent ? or ? bond, dashed line represents the presence or absence of a bond W, Y, Z, R, R1, R2 and R3 are as defined in the specification.
    Type: Grant
    Filed: August 28, 2003
    Date of Patent: March 21, 2006
    Assignee: Allergan, Inc.
    Inventors: David W. Old, Robert M. Burk, Thang D. Dinh
  • 8-azaprostaglandin carbonate and thiocarbonate analogs as therapeutic agents
    Patent number: 7005442
    Abstract: The present invention provides a compound represented by the general formula I; wherein A, Ar, X, Z, n, x, y, R and R3 are as defined in the specification.
    Type: Grant
    Filed: September 1, 2004
    Date of Patent: February 28, 2006
    Assignee: Allergan, Inc.
    Inventors: David W. Old, Thang D. Dinh, Robert M. Burk
  • 8-azaprostaglandin carbonate and thiocarbonate analogs as therapeutic agents
    Patent number: 6812240
    Abstract: The present invention provides a compound represented by the general formula I; wherein A, Ar, X, Z, n, x, y, R and R3 are as defined in the specification.
    Type: Grant
    Filed: January 26, 2004
    Date of Patent: November 2, 2004
    Assignee: Allergan, Inc.
    Inventors: David W. Old, Thang D. Dinh, Robert M. Burk
  • Piperidinyl prostaglandin E analogs
    Patent number: 6747037
    Abstract: The present invention provides a method of treating ocular hypertension or glaucoma which comprises administering to an animal having ocular hypertension or glaucoma therapeutically effective amount of a compound represented by the general formula I; wherein X, Y, Z, D and R3 are as defined in the specification.
    Type: Grant
    Filed: June 6, 2003
    Date of Patent: June 8, 2004
    Assignee: Allergan, Inc.
    Inventors: David W. Old, Thang D. Dinh
  • 8-Azaprostaglandin carbonate and thiocarbonate analogs as therapeutic agents
    Patent number: 6734201
    Abstract: The present invention provides a compound represented by the general formula I; wherein A, Ar, X, Z, n, x, y, R and R3 are as defined in the specification.
    Type: Grant
    Filed: June 2, 2003
    Date of Patent: May 11, 2004
    Assignee: Allergan, Inc.
    Inventors: David W. Old, Thang D. Dinh, Robert M. Burk
  • 3-oxa-8-azaprostaglandin analogs as agents for lowering intraocular pressure
    Patent number: 6734206
    Abstract: The present invention provides a method of treating ocular hypertension or glaucoma which comprises administering to an animal having ocular hypertension or glaucoma therapeutically effective amount of a compound represented by the general formula I; wherein X, Y, Z, D and R3 are as defined in the specification.
    Type: Grant
    Filed: June 2, 2003
    Date of Patent: May 11, 2004
    Assignee: Allergan, Inc.
    Inventors: David W. Old, Thang D. Dinh, Robert M. Burk